Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine

NCT00304265 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis
Diphtheria
Tetanus
Poliomyelitis

Interventions

BIOLOGICAL: COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®)

Sponsor

Sanofi Pasteur, a Sanofi Company